The Dyer bacterial assay system holds the top market share among domestic brands in China.
Release Date:
2014-10-08
According to statistics compiled by the National Health and Family Planning Commission’s Expert Committee on Rational Drug Use, the National Bacterial Resistance Surveillance Network, Peking Union Medical College Hospital, and other institutions—based on antimicrobial susceptibility testing data from 1,141 key hospitals that had joined the national surveillance network as of the end of the third quarter of 2014—the DL‑96II bacterial identification system holds an 11.6% market share, ranking first among domestic Chinese brands. This marks a significant milestone for China’s indigenous brands in the field of clinical microbiological diagnostics. After years of dedicated effort, these domestic brands have emerged as a major force in a clinical microbiology diagnostics market long dominated by foreign competitors.
According to the National Rational Drug Use Expert Committee of the National Health and Family Planning Commission, the National Bacterial Resistance Surveillance Network, Peking Union Medical College Hospital, and other institutions, as of…
At the end of the third quarter of 2014, Already included in the National Bacterial Resistance Surveillance Network 1141 Statistics based on the antimicrobial susceptibility testing systems used by major hospitals.
The market share of the Dyer bacterial assay system (DL-96II) is 11.6%. Topping the domestic ethnic-brand rankings 。
This is clinical microbiological diagnosis. National brand Domestic clinical Major advances achieved in the field of bed testing 。
National brand After years of hard work, it has finally emerged as a major player in the clinical microbiology diagnostics market, which is dominated by foreign brands.

The Difco bacterial identification system can identify more than 600 bacterial species across 11 major clinical categories.
The system offers a comprehensive panel of antibiotics for antimicrobial susceptibility testing, updated annually in accordance with the latest CLSI guidelines.
MIC analysis results classify antimicrobial agents into groups A, B, C, and U, facilitating physicians in selecting the optimal antibiotic.
The results report provides scientifically sound annotations of antimicrobial susceptibility test outcomes in accordance with CLSI standards, thereby guiding the rational use of antimicrobial agents in clinical practice.
In the face of international competition, Deere has, through relentless effort and continuous improvement, earned the trust of customers at all levels with its high-quality products and sincere service.
The trust of the hospital’s many users.
It has contributed Chinese expertise to the field of clinical microbiology and brought honor to China’s national enterprises.
Related News